Adage Capital Partners
BCAB icon

Adage Capital Partners’s BioAtla BCAB Stock Holding History

Adage Capital Partners’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,000
Closed -$1.48M – 877
2023
Q4 		$1.48M Sell
12,000
-23,923
-67% -$2.07M ﹤0.01% 751
2023
Q3 		$3.05M Sell
35,923
-1,976
-5% -$252K 0.01% 716
2023
Q2 		$5.68M Buy
37,899
+6,000
+19% +$1.03M 0.01% 656
2023
Q1 		$4.27M Sell
31,899
-3,101
-9% -$559K 0.01% 723
2022
Q4 		$14.4M Buy
+35,000
New +$14.5M 0.03% 534

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Adage Capital Partners's BCAB Position: Q1 2024 in Review

Adage Capital Partners sold out of BioAtla (BCAB) in Q1 2024, closing a stake of 12,000 shares — an estimated $1.48M sold.

Adage Capital Partners first reported a position in BCAB in Q4 2022 and held it in 5 quarters. The position peaked at $14.4M in Q4 2022. 82 funds tracked by Wall St. Rank hold BCAB as of Q1 2024.

  • Adage Capital Partners reported no remaining BioAtla position as of Q1 2024 after selling out during the quarter.
  • Adage Capital Partners sold 12,000 BioAtla shares in Q1 2024, an estimated $1.48M.
  • Adage Capital Partners first reported a position in BioAtla in Q4 2022 and held it in 5 quarters.
  • Adage Capital Partners's BioAtla position peaked at $14.4M in Q4 2022.
  • 82 funds tracked by Wall St. Rank held BioAtla as of Q1 2024.

Based on Adage Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.